#  Leo Kim, MD, PhD, to Receive ARVO Kreissig Award 

 





December 19, 2025

 

 

 ![Dr. Leo Kim](/sites/g/files/omnuum9886/files/eye/files/kim_leo_updated_preferred_01.jpg)

 

Leo Kim, MD, PhD, Associate Professor of Ophthalmology at Harvard Medical School, was selected to receive the Kreissig Award, established in 2020 by Ingrid Kreissig, MD, through an ARVO Foundation endowment. The award recognizes early-career investigators advancing clinically relevant and translatable innovations in retinal surgery.

Dr. Kim's work focuses on elucidating the molecular and cellular mechanisms underlying pathologic angiofibrosis and neovascularization in retinal diseases such as age-related macular degeneration (AMD), diabetic retinopathy and proliferative vitreoretinopathy (PVR). A primary focus of his laboratory is the transcription factor RUNX1, which he has identified as a key regulator of aberrant retinal angiogenesis and fibrosis. His work has demonstrated that RUNX1 inhibition modulates choroidal neovascularization and synergizes with anti-VEGF therapies to reduce vascular leakage in AMD models. This discovery opens new therapeutic avenues for exudative AMD.



 

 

 



 

 See also:- [ Awards ](/category/awards)
- [ Faculty ](/news-categories/faculty)
- [ Leo A. Kim, MD, PhD ](/news-categories/leokim)
 
 

 Share on:- [     Facebook ](#)
- [     Twitter ](#)
- [     Linkedin ](#)